Nuvation Bio Inc (NUVB) Notes From Management Meetings - Jefferies

April 20, 2021 8:23 AM EDT Send to a Friend
Jefferies analyst Michael Yee reiterated a Buy rating and $20.00 price target on Nuvation Bio Inc (NYSE: NUVB) after hosting ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login